STOCK TITAN

[8-K] Vaxart, Inc Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Credo Technology Group Holding Ltd (CRDO) – Form 4 filing dated 07/08/2025

President & CEO William J. Brennan reported a Rule 16 transaction code “F”, indicating shares were withheld by the company on 07/05/2025 to cover tax obligations arising from restricted-stock-unit (RSU) vesting. A total of 6,149 ordinary shares were disposed at an accounting price of $93.61 per share (≈ $575 k in value). Following the transaction, Brennan still owns 439,782 shares directly and 2,211,978 shares indirectly through The Brennan Family Trust, leaving his total beneficial stake at roughly 2.65 million shares.

The filing reflects a routine, non-cash settlement rather than an open-market sale. Ownership concentration by the CEO remains high, signalling continued alignment with common shareholders. No derivative securities were involved and there are no indications of changes in executive roles or other material corporate events.

Credo Technology Group Holding Ltd (CRDO) – Comunicazione Form 4 datata 08/07/2025

Il Presidente e CEO William J. Brennan ha segnalato una transazione ai sensi della Regola 16 con codice “F”, indicando che il 05/07/2025 la società ha trattenuto azioni per coprire obblighi fiscali derivanti dalla maturazione di unità azionarie vincolate (RSU). In totale sono state disposte 6.149 azioni ordinarie a un prezzo contabile di $93,61 per azione (circa $575.000 di valore). Dopo la transazione, Brennan detiene ancora 439.782 azioni direttamente e 2.211.978 azioni indirettamente tramite The Brennan Family Trust, per un totale di circa 2,65 milioni di azioni.

La comunicazione riflette una normale operazione di regolamento non in contanti e non una vendita sul mercato aperto. La concentrazione della proprietà da parte del CEO rimane elevata, segnalando un continuo allineamento con gli azionisti comuni. Non sono stati coinvolti strumenti derivati e non ci sono indicazioni di cambiamenti nei ruoli esecutivi o altri eventi societari rilevanti.

Credo Technology Group Holding Ltd (CRDO) – Presentación del Formulario 4 con fecha 08/07/2025

El Presidente y CEO William J. Brennan reportó una transacción bajo la Regla 16 con código “F”, indicando que el 05/07/2025 la compañía retuvo acciones para cubrir obligaciones fiscales derivadas del vencimiento de unidades de acciones restringidas (RSU). En total se dispusieron 6,149 acciones ordinarias a un precio contable de $93.61 por acción (aproximadamente $575,000 en valor). Tras la transacción, Brennan posee aún 439,782 acciones directamente y 2,211,978 acciones indirectamente a través de The Brennan Family Trust, sumando un total aproximado de 2.65 millones de acciones.

La presentación refleja una liquidación rutinaria no en efectivo y no una venta en el mercado abierto. La concentración de propiedad por parte del CEO sigue siendo alta, indicando una continua alineación con los accionistas comunes. No se involucraron valores derivados y no hay indicios de cambios en roles ejecutivos u otros eventos corporativos materiales.

Credo Technology Group Holding Ltd (CRDO) – 2025년 7월 8일자 Form 4 제출

회장 겸 CEO 윌리엄 J. 브레넌은 규칙 16 거래 코드 “F”를 보고했으며, 이는 2025년 7월 5일에 제한 주식 단위(RSU) 권리 행사에 따른 세금 의무를 충당하기 위해 회사가 주식을 보류했음을 나타냅니다. 총 6,149 보통주가 주당 $93.61의 회계 가격으로 처분되어 (약 $575,000 상당) 처리되었습니다. 거래 후 브레넌은 직접 439,782주The Brennan Family Trust를 통해 간접적으로 2,211,978주를 보유하여 총 약 265만 주의 실질 지분을 유지하고 있습니다.

이번 제출은 공개 시장 매도가 아닌 일상적인 비현금 결제임을 반영합니다. CEO의 소유 집중도는 여전히 높아 일반 주주들과의 지속적인 이해관계 일치를 시사합니다. 파생 증권은 포함되지 않았으며 경영진 역할 변경이나 기타 중요한 기업 사건에 대한 징후도 없습니다.

Credo Technology Group Holding Ltd (CRDO) – Dépôt du Formulaire 4 daté du 08/07/2025

Le Président et CEO William J. Brennan a déclaré une transaction selon la Règle 16 avec le code « F », indiquant que le 05/07/2025 la société a retenu des actions pour couvrir des obligations fiscales liées à l'acquisition de Restricted Stock Units (RSU). Un total de 6 149 actions ordinaires ont été cédées à un prix comptable de 93,61 $ par action (soit environ 575 000 $ de valeur). Après la transaction, Brennan détient toujours 439 782 actions en direct et 2 211 978 actions indirectement via The Brennan Family Trust, portant sa participation bénéficiaire totale à environ 2,65 millions d’actions.

Le dépôt reflète un règlement courant non monétaire plutôt qu’une vente sur le marché ouvert. La concentration de la propriété par le CEO reste élevée, témoignant d’un alignement continu avec les actionnaires ordinaires. Aucun produit dérivé n’a été impliqué et il n’y a aucune indication de changements dans les fonctions exécutives ou d’autres événements d’entreprise importants.

Credo Technology Group Holding Ltd (CRDO) – Form 4 Einreichung vom 08.07.2025

Präsident und CEO William J. Brennan meldete eine Regel 16 Transaktion mit Code „F“, was darauf hinweist, dass am 05.07.2025 Aktien vom Unternehmen einbehalten wurden, um Steuerverpflichtungen aus der Vesting-Phase von Restricted Stock Units (RSU) zu begleichen. Insgesamt wurden 6.149 Stammaktien zu einem Buchwert von $93,61 pro Aktie veräußert (≈ $575.000 Wert). Nach der Transaktion hält Brennan weiterhin 439.782 Aktien direkt und 2.211.978 Aktien indirekt über The Brennan Family Trust, womit sein gesamtes wirtschaftliches Interesse bei etwa 2,65 Millionen Aktien liegt.

Die Meldung spiegelt eine routinemäßige, nicht-barriere Abwicklung wider und keinen Verkauf am offenen Markt. Die Eigentumskonzentration des CEO bleibt hoch, was auf eine fortgesetzte Ausrichtung mit den Stammaktionären hinweist. Es waren keine Derivate involviert und es gibt keine Anzeichen für Änderungen in der Geschäftsführung oder andere wesentliche Unternehmensereignisse.

Positive
  • High insider ownership: CEO retains approximately 2.65 million shares after the transaction, demonstrating continued alignment with shareholder interests.
Negative
  • None.

Insights

TL;DR: Routine tax-withholding sale; CEO still holds ~2.65 m CRDO shares, so investor impact is minimal.

The Form 4 shows an F-code transaction, meaning the shares were surrendered to the issuer to satisfy RSU tax liabilities rather than sold on the open market. Only 6,149 shares (≈0.23 % of Brennan’s total holdings) were affected, leaving his ownership essentially intact. Such administrative movements do not alter supply-demand dynamics, capital structure, or signal a change in sentiment. Accordingly, I view the disclosure as neutral and not financially material.

TL;DR: Governance-neutral filing; maintains strong insider alignment, no red flags.

From a governance standpoint, code F transactions are expected when RSUs vest. Brennan’s remaining 2.65 m-share stake continues to align management interests with shareholders. The disclaimer on the trust indicates appropriate separation of personal and fiduciary holdings. No additional related-party issues or accelerated sales are evident. Therefore, the filing is procedural and non-impactful.

Credo Technology Group Holding Ltd (CRDO) – Comunicazione Form 4 datata 08/07/2025

Il Presidente e CEO William J. Brennan ha segnalato una transazione ai sensi della Regola 16 con codice “F”, indicando che il 05/07/2025 la società ha trattenuto azioni per coprire obblighi fiscali derivanti dalla maturazione di unità azionarie vincolate (RSU). In totale sono state disposte 6.149 azioni ordinarie a un prezzo contabile di $93,61 per azione (circa $575.000 di valore). Dopo la transazione, Brennan detiene ancora 439.782 azioni direttamente e 2.211.978 azioni indirettamente tramite The Brennan Family Trust, per un totale di circa 2,65 milioni di azioni.

La comunicazione riflette una normale operazione di regolamento non in contanti e non una vendita sul mercato aperto. La concentrazione della proprietà da parte del CEO rimane elevata, segnalando un continuo allineamento con gli azionisti comuni. Non sono stati coinvolti strumenti derivati e non ci sono indicazioni di cambiamenti nei ruoli esecutivi o altri eventi societari rilevanti.

Credo Technology Group Holding Ltd (CRDO) – Presentación del Formulario 4 con fecha 08/07/2025

El Presidente y CEO William J. Brennan reportó una transacción bajo la Regla 16 con código “F”, indicando que el 05/07/2025 la compañía retuvo acciones para cubrir obligaciones fiscales derivadas del vencimiento de unidades de acciones restringidas (RSU). En total se dispusieron 6,149 acciones ordinarias a un precio contable de $93.61 por acción (aproximadamente $575,000 en valor). Tras la transacción, Brennan posee aún 439,782 acciones directamente y 2,211,978 acciones indirectamente a través de The Brennan Family Trust, sumando un total aproximado de 2.65 millones de acciones.

La presentación refleja una liquidación rutinaria no en efectivo y no una venta en el mercado abierto. La concentración de propiedad por parte del CEO sigue siendo alta, indicando una continua alineación con los accionistas comunes. No se involucraron valores derivados y no hay indicios de cambios en roles ejecutivos u otros eventos corporativos materiales.

Credo Technology Group Holding Ltd (CRDO) – 2025년 7월 8일자 Form 4 제출

회장 겸 CEO 윌리엄 J. 브레넌은 규칙 16 거래 코드 “F”를 보고했으며, 이는 2025년 7월 5일에 제한 주식 단위(RSU) 권리 행사에 따른 세금 의무를 충당하기 위해 회사가 주식을 보류했음을 나타냅니다. 총 6,149 보통주가 주당 $93.61의 회계 가격으로 처분되어 (약 $575,000 상당) 처리되었습니다. 거래 후 브레넌은 직접 439,782주The Brennan Family Trust를 통해 간접적으로 2,211,978주를 보유하여 총 약 265만 주의 실질 지분을 유지하고 있습니다.

이번 제출은 공개 시장 매도가 아닌 일상적인 비현금 결제임을 반영합니다. CEO의 소유 집중도는 여전히 높아 일반 주주들과의 지속적인 이해관계 일치를 시사합니다. 파생 증권은 포함되지 않았으며 경영진 역할 변경이나 기타 중요한 기업 사건에 대한 징후도 없습니다.

Credo Technology Group Holding Ltd (CRDO) – Dépôt du Formulaire 4 daté du 08/07/2025

Le Président et CEO William J. Brennan a déclaré une transaction selon la Règle 16 avec le code « F », indiquant que le 05/07/2025 la société a retenu des actions pour couvrir des obligations fiscales liées à l'acquisition de Restricted Stock Units (RSU). Un total de 6 149 actions ordinaires ont été cédées à un prix comptable de 93,61 $ par action (soit environ 575 000 $ de valeur). Après la transaction, Brennan détient toujours 439 782 actions en direct et 2 211 978 actions indirectement via The Brennan Family Trust, portant sa participation bénéficiaire totale à environ 2,65 millions d’actions.

Le dépôt reflète un règlement courant non monétaire plutôt qu’une vente sur le marché ouvert. La concentration de la propriété par le CEO reste élevée, témoignant d’un alignement continu avec les actionnaires ordinaires. Aucun produit dérivé n’a été impliqué et il n’y a aucune indication de changements dans les fonctions exécutives ou d’autres événements d’entreprise importants.

Credo Technology Group Holding Ltd (CRDO) – Form 4 Einreichung vom 08.07.2025

Präsident und CEO William J. Brennan meldete eine Regel 16 Transaktion mit Code „F“, was darauf hinweist, dass am 05.07.2025 Aktien vom Unternehmen einbehalten wurden, um Steuerverpflichtungen aus der Vesting-Phase von Restricted Stock Units (RSU) zu begleichen. Insgesamt wurden 6.149 Stammaktien zu einem Buchwert von $93,61 pro Aktie veräußert (≈ $575.000 Wert). Nach der Transaktion hält Brennan weiterhin 439.782 Aktien direkt und 2.211.978 Aktien indirekt über The Brennan Family Trust, womit sein gesamtes wirtschaftliches Interesse bei etwa 2,65 Millionen Aktien liegt.

Die Meldung spiegelt eine routinemäßige, nicht-barriere Abwicklung wider und keinen Verkauf am offenen Markt. Die Eigentumskonzentration des CEO bleibt hoch, was auf eine fortgesetzte Ausrichtung mit den Stammaktionären hinweist. Es waren keine Derivate involviert und es gibt keine Anzeichen für Änderungen in der Geschäftsführung oder andere wesentliche Unternehmensereignisse.

false 0000072444 0000072444 2025-07-08 2025-07-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): July 8, 2025
 
Vaxart, Inc.
(Exact name of registrant as specified in its charter)
   
Delaware
 
001-35285
 
59-1212264
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
170 Harbor Way, Suite 300, South San Francisco, California
 
94080
(Address of principal executive offices)
 
(Zip Code)
   
Registrant’s telephone number, including area code: (650) 550-3500
   
Not Applicable
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading symbol
 
Name of each exchange on which registered
Common Stock, $0.0001 par value
 
VXRT (1)
 
The Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging Growth Company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

(1) Vaxart, Inc. (the “Company”) received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) of its determination to delist the Company’s common stock as a result of the Company’s ongoing failure to comply with the minimum bid price requirement (the “Minimum Bid Price Requirement”) for continued listing under Nasdaq Listing Rule 5550(a)(2) on The Nasdaq Capital Market. Accordingly, trading in the Company’s common stock on Nasdaq was suspended at the open of trading on July 8, 2025. Since July 8, 2025, the Company’s common stock has traded on the OTCQX Best Market of the OTC Markets Group under the trading symbol “VXRT”. The Company appealed Nasdaq’s delisting determination on July 3, 2025 and its common stock remains suspended on Nasdaq during such appeal.
 
 

 
Item 8.01 Other Events.
 
On July 8, 2025, Vaxart, Inc. (the “Company”) issued a press release announcing that the Company’s common stock has been approved to trade on the OTCQX® Best Market. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and, other than the quote by Mr. Steven Lo, is incorporated by reference herein.
 
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits
 
Exhibit
 
Description
     
99.1
 
Press Release, dated July 8, 2025.
     
104
 
Cover Page Interactive Data File (embedded within Inline XBRL document).
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: July 8, 2025
 
VAXART, INC.
     
 
By:
/s/ Steven Lo
   
Steven Lo
   
Chief Executive Officer
   
 

FAQ

How many CRDO shares did CEO William Brennan dispose in the 07/05/2025 transaction?

He disposed of 6,149 ordinary shares, withheld to satisfy RSU tax obligations.

What price was used to value the CRDO shares withheld for taxes?

The accounting price was $93.61 per share.

How many CRDO shares does Brennan own after this Form 4 filing?

He beneficially owns 439,782 shares directly and 2,211,978 shares indirectly via The Brennan Family Trust.

Was this an open-market sale by the CEO?

No. The code F transaction reflects issuer-withheld shares to cover tax liabilities from RSU vesting.

Did the filing signal any change in Brennan’s role at Credo Technology?

No. Brennan remains President & CEO and a member of the Board.
Vaxart Inc

OTC:VXRT

VXRT Rankings

VXRT Latest News

VXRT Latest SEC Filings

VXRT Stock Data

103.16M
225.15M
0.77%
15.81%
5.84%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO